Kreatech

Amsterdam, Netherlands Founded: 1996 • Age: 30 yrs Acquired By Leica Biosystems
Novel FISH probes are developed for genetic aberration detection.
Request Access

About Kreatech

Kreatech is a company based in Amsterdam (Netherlands) founded in 1996 was acquired by Leica Biosystems in July 2013.. Kreatech has raised $3.02 million across 1 funding round from investors including Life Sciences Partners, Alafi Capital and Leica Biosystems. Kreatech operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.

  • Headquarter Amsterdam, Netherlands
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.02 M (USD)

    in 1 rounds

  • Latest Funding Round
    $3.02 M (USD), Series A

    Nov 27, 2009

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Leica Biosystems

    (Jul 08, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Kreatech

Kreatech has successfully raised a total of $3.02M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.02 million completed in November 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $3.0M
  • First Round

    (27 Nov 2009)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2009 Amount Series A - Kreatech Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Kreatech

Kreatech has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Life Sciences Partners, Alafi Capital and Leica Biosystems. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Life-Sciences focused early & growth stage VC firm investing in the US & Europe
Founded Year Domain Location
Private equity investments in life sciences businesses are managed.
Founded Year Domain Location
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Kreatech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Kreatech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kreatech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kreatech

Kreatech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
RNA-sequencing transcriptome kits for health data analysis are developed.
domain founded_year HQ Location
Molecular diagnostic assays are developed for target DNA sequence detection.
domain founded_year HQ Location
Developer of technologies for the analysis of rare and single cells in the blood
domain founded_year HQ Location
Products and reagents for molecular diagnostic assays are supplied.
domain founded_year HQ Location
Developer of nucleic acid detection and quantification systems
domain founded_year HQ Location
Electrophoresis-based in vitro diagnostics products are developed and provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Kreatech

Frequently Asked Questions about Kreatech

When was Kreatech founded?

Kreatech was founded in 1996 and raised its 1st funding round 13 years after it was founded.

Where is Kreatech located?

Kreatech is headquartered in Amsterdam, Netherlands.

Is Kreatech a funded company?

Kreatech is a funded company, having raised a total of $3.02M across 1 funding round to date. The company's 1st funding round was a Series A of $3.02M, raised on Nov 27, 2009.

What does Kreatech do?

Kreatech was founded in 1996 in Amsterdam, Netherlands, within the biotechnology sector. FISH probes are developed for detecting and quantifying genetic aberrations linked to cancer and other diseases. A portfolio of REPEAT-FREE DNA-FISH probes is offered, along with microarray labeling solutions based on the proprietary Universal Linkage System technology. Operations focus on enabling diagnostic applications in research and clinical settings.

Who are the top competitors of Kreatech?

Kreatech's top competitors include Neogen, Qiagen and Parse Biosciences.

Who are Kreatech's investors?

Kreatech has 3 investors. Key investors include Life Sciences Partners, Alafi Capital, and Leica Biosystems.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available